| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 182 |
| 1 | MACITENTAN | 143 |
| 2 | TREPROSTINIL | 132 |
| 3 | TADALAFIL | 118 |
| 4 | SILDENAFIL CITRATE | 111 |
| 5 | AMBRISENTAN | 91 |
| 6 | SILDENAFIL | 76 |
| 7 | FUROSEMIDE | 53 |
| 8 | 0XYGEN | 49 |
| 9 | OXYGEN | 49 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 182 | 0.0139 |
| 1 | COLLOIDAL SILVER | 1 | 0.0116 |
| 2 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 2 | 0.0026 |
| 3 | MACITENTAN | 143 | 0.0020 |
| 4 | BUTALBITAL AND ACETAMINOPHEN | 1 | 0.0016 |
| 5 | AIRBORNE | 1 | 0.0015 |
| 6 | FOSCARBIDOPA/FOSLEVODOPA | 11 | 0.0012 |
| 7 | TADALAFIL | 118 | 0.0012 |
| 8 | RIOCIGUAT | 37 | 0.0011 |
| 9 | MIRVETUXIMAB SORAVTANSINE | 2 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 284 |
| 1 | Endothelin Receptor Antagonist [EPC] | 220 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 148 |
| 3 | Loop Diuretic [EPC] | 69 |
| 4 | Osmotic Laxative [EPC] | 42 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 37 |
| 6 | Aldosterone Antagonist [EPC] | 32 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32 |
| 8 | Potassium Salt [EPC] | 24 |
| 9 | Prostacyclin Receptor Agonist [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 284 | 0.0021 |
| 1 | Non-Standardized House Dust Allergenic Extract [EPC] | 1 | 0.0013 |
| 2 | Standardized Animal Hair Allergenic Extract [EPC] | 1 | 0.0012 |
| 3 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 4 | Endothelin Receptor Antagonist [EPC] | 220 | 0.0011 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 148 | 0.0011 |
| 6 | Soluble Guanylate Cyclase Stimulator [EPC] | 37 | 0.0011 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 21 | 0.0008 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 8 | 0.0006 |
| 9 | Antiseptic [EPC] | 2 | 0.0005 |